# The Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024, Regulation 8: Amendment to regulation 250


In regulation 250 (exceptions to regulation 249), after paragraph (4A) insert—
“(4B) A person may, in the course of a business consisting (wholly or partly) of manufacturing medicinal products, or of selling products by way of wholesale dealing, sell or supply by way of wholesale dealing a naloxone product that is a prescription only medicine to—
(a) providers of drug treatment services that have arrangements as mentioned in regulation 237A(2)(a);
(b) the medical services of His Majesty’s forces;
(c) the bodies mentioned in regulation 237A(2)(c); and
(d) local naloxone providers.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2024/9780348262797/regulation/8 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendments-relating-to-naloxone-and-transfers-of-functions-regulations-2024/regulation-8
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

